secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scienture Holdings, Inc. (SCNX)
CIK:        0001382574
Form:       8-K
Filed at:   2023-06-26T23:59:59+00:00
Accession:  0001493152-23-022532
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRxADE Health receives Nasdaq delisting notice for insufficient public shares
-----------------------------------------------------------------------------

- Nasdaq notified TRxADE on June 23, 2023, that it had ~310,057 publicly held shares, below the 500,000 minimum.
- Company must submit a compliance plan by August 7, 2023; failure may result in delisting from Nasdaq.
- Created Series B Preferred Stock, each share converting into 100 common shares upon stockholder approval.
- If merger with Superlatus, Inc. does not close by Dec 31, 2023, Company will repurchase all Series B shares at original cost.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382574/000149315223022532/0001493152-23-022532-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382574/000149315223022532/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-022532

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer